Bellucci M, Romani C, Sani M, Volonterio A
Antibiotics (Basel). 2024; 13(8).
PMID: 39200083
PMC: 11352213.
DOI: 10.3390/antibiotics13080783.
Bing C, Mengjuan A, Xinyu M, Chixin Z, Xinyao T, Yan S
Future Microbiol. 2024; 19(9):771-782.
PMID: 38683168
PMC: 11290751.
DOI: 10.2217/fmb-2023-0272.
Lennard P, Hiemstra P, Nibbering P
Antibiotics (Basel). 2023; 12(10).
PMID: 37887219
PMC: 10604037.
DOI: 10.3390/antibiotics12101518.
Alsaggar M, Al-Hazabreh M, Al Tall Y, Al-Tarawneh A, Darweesh R, Masadeh M
Saudi Pharm J. 2022; 30(11):1652-1658.
PMID: 36465844
PMC: 9715947.
DOI: 10.1016/j.jsps.2022.09.009.
Zhao Y, Wang X, Sun Y, Li Z, Liu T, Liu Q
World J Microbiol Biotechnol. 2022; 38(9):162.
PMID: 35834028
DOI: 10.1007/s11274-022-03333-1.
Structurally nanoengineered antimicrobial peptide polymers: design, synthesis and biomedical applications.
Ramamurthy R, Mehta C, Nayak U
World J Microbiol Biotechnol. 2021; 37(8):139.
PMID: 34278535
PMC: 8286942.
DOI: 10.1007/s11274-021-03109-z.
SppI Forms a Membrane Protein Complex with SppA and Inhibits Its Protease Activity in Bacillus subtilis.
Henriques G, McGovern S, Neef J, Antelo-Varela M, Gotz F, Otto A
mSphere. 2020; 5(5).
PMID: 33028682
PMC: 7568657.
DOI: 10.1128/mSphere.00724-20.
Expression and Roles of Antimicrobial Peptides in Innate Defense of Airway Mucosa: Potential Implication in Cystic Fibrosis.
Geitani R, Ayoub Moubareck C, Xu Z, Karam Sarkis D, Touqui L
Front Immunol. 2020; 11:1198.
PMID: 32695100
PMC: 7338688.
DOI: 10.3389/fimmu.2020.01198.
Biological Properties, Current Applications and Potential Therapeautic Applications of Brevinin Peptide Superfamily.
Zohrab F, Askarian S, Jalili A, Kazemi Oskuee R
Int J Pept Res Ther. 2020; 25(1):39-48.
PMID: 32214928
PMC: 7087712.
DOI: 10.1007/s10989-018-9723-8.
Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
Geitani R, Ayoub Moubareck C, Touqui L, Karam Sarkis D
BMC Microbiol. 2019; 19(1):54.
PMID: 30849936
PMC: 6408789.
DOI: 10.1186/s12866-019-1416-8.
Antimicrobial Peptides: the Achilles' Heel of Antibiotic Resistance?.
Lewies A, du Plessis L, Wentzel J
Probiotics Antimicrob Proteins. 2018; 11(2):370-381.
PMID: 30229514
DOI: 10.1007/s12602-018-9465-0.
A3, a Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug Resistant Gram Positive Bacteria.
Almaaytah A, Farajallah A, Abualhaijaa A, Al-Balas Q
Molecules. 2018; 23(7).
PMID: 30004427
PMC: 6100099.
DOI: 10.3390/molecules23071603.
Hybridization and antibiotic synergism as a tool for reducing the cytotoxicity of antimicrobial peptides.
Almaaytah A, Qaoud M, Abualhaijaa A, Al-Balas Q, Alzoubi K
Infect Drug Resist. 2018; 11:835-847.
PMID: 29910626
PMC: 5987794.
DOI: 10.2147/IDR.S166236.
Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine.
Almaaytah A, Qaoud M, Mohammed G, Abualhaijaa A, Knappe D, Hoffmann R
Pharmaceuticals (Basel). 2018; 11(1).
PMID: 29301331
PMC: 5874699.
DOI: 10.3390/ph11010003.
Macropis fulvipes Venom component Macropin Exerts its Antibacterial and Anti-Biofilm Properties by Damaging the Plasma Membranes of Drug Resistant Bacteria.
Ko S, Kim M, Bang J, Seo C, Luchian T, Park Y
Sci Rep. 2017; 7(1):16580.
PMID: 29185466
PMC: 5707368.
DOI: 10.1038/s41598-017-16784-6.
Development of novel ultrashort antimicrobial peptide nanoparticles with potent antimicrobial and antibiofilm activities against multidrug-resistant bacteria.
Almaaytah A, Mohammed G, Abualhaijaa A, Al-Balas Q
Drug Des Devel Ther. 2017; 11:3159-3170.
PMID: 29138537
PMC: 5679673.
DOI: 10.2147/DDDT.S147450.
Antimicrobial and Antioxidant Activities of the Extract and Fractions of Tetradenia riparia (Hochst.) Codd (Lamiaceae) Leaves from Brazil.
Fernandez A, Rosa M, Fernandez C, C Bortolucci W, Melo U, Siqueira V
Curr Microbiol. 2017; 74(12):1453-1460.
PMID: 28840299
DOI: 10.1007/s00284-017-1340-9.
Synthesis and Evaluation of Antimicrobial Activity of [R₄W₄K]-Levofloxacin and [R₄W₄K]-Levofloxacin-Q Conjugates.
Riahifard N, Tavakoli K, Yamaki J, Parang K, Tiwari R
Molecules. 2017; 22(6).
PMID: 28594345
PMC: 6152667.
DOI: 10.3390/molecules22060957.
Synergistic activity of synthetic N-terminal peptide of human lactoferrin in combination with various antibiotics against carbapenem-resistant Klebsiella pneumoniae strains.
Morici P, Florio W, Rizzato C, Ghelardi E, Tavanti A, Rossolini G
Eur J Clin Microbiol Infect Dis. 2017; 36(10):1739-1748.
PMID: 28470337
DOI: 10.1007/s10096-017-2987-7.